心理应激与非酒精性脂肪性肝病

doi:10.3969/j.issn.1672-5069.2016.06.036

Abstract

Abstract: Nonalcoholic fatty liver disease （NAFLD） is thought to be mainly caused by over-eating and sedentary lifestyle， while it can hardly explain the incidence of non-obese NAFLD. Recently，other possible causes and mechanisms has become a new research spot. It’s very hard for a patient with NAFLD to stick to a well-designed living regimen，so giving an overall and more effective treatment has now become another hotspot. This article reviewed the psychological stress，emotions，such as depression and anxiety，imbalance of hypothalamic-pituitary-adrenal（HPA） axis，glucose and lipid metabolism disorders， and immuno-inflammatory responses in the development of NAFLD.

Key words: Nonalcoholic fatty liver disease, Psychological stress, Depression, Anxiety

Tao Yeting，Fan Jiangao.. Psychological stress in nonalcoholic fatty liver diseases[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(6): 753-756.

References

[1] D’souza AM，Beaudry JL，Szigiato AA，et al. Consumption of a high-fat diet rapidly exacerbates the development of fatty liver disease that occurs with chronically elevated glucocorticoids. Am J Physiol gastrointest Liver Physiol，2012，302（8）:G850-G863.
[2] Blachier M，Leleu H，Peck-Radosavljevic M，et al. The burden of liver disease in Europe:a review of available epidemiological data. J Hepatol，2013，58（3）:593-608.
[3] Fan JG. Epidemiology of alcoholic and nonalcoholic fatty liver disease in China. J Gastroenterol Hepatol,2013,28（Suppl 1）:11-17.
[4] David K,Kowdley KVm，Unalp A，et al. Quality of life in adults with nonalcoholic fatty liver disease:Baseline data from the NASH CRN. Hepatology，2009，49（6）:1904-1912.
[5] Russ TC，Kivimki M，Morling JR，et al. Association between psychological distress and liver disease mortality:a meta-analysis of individual study participants. Gastroenterology，2015，148（5）:958-966.
[6] Puustinen PJ，Koponen H，Kautiainen H，et al. Psychological distress predicts the development of the metabolic syndrome:a prospective population-based study. Psychosom Med，2011，73（2）:158-165.
[7] Kouvonen A，Stafford M，De Vogli R，et al. Negative aspects of close relationships as a predictor of increased body mass index and waist circumference:the Whitehall II study. Am J Public Health，2011，101（8）:1474-1480.
[8] Hsieh SD，Muto T，Murase T，et al. Association of short sleep duration with obesity，diabetes，fatty liver and behavioral factors in Japanese men. Intern Med，2011，50（21）:2499-2502.
[9] Das K，Das K，Mukherjee PS，et al. Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease. Hepatology，2010，51（5）:1593-1602.
[10] Liu YZ，Chen JK，Zhang Y，et al. Chronic stress induces steatohepatitis while decreases visceral fat mass in mice. BMC Gastroenterol，2014，14:106.
[11] Macedo IC，Medeiros LF，Oliveira C，et al. Cafeteria diet-induced obesity plus chronic stress alter serum leptin levels. Peptides， 2012，38（1）:189-196.
[12] Czech B，Neumann ID，Müller M，et al. Effect of chronic psychosocial stress on nonalcoholic steatohepatitis in mice. Int J Clin Exp Pathol，2013，6（8）:1585-1593.
[13] Strekalova T，Evans M，Costa-Nunes J，et al. Tlr4 upregulation in the brain accompanies depression-and anxiety-like behaviors induced by a high-cholesterol diet. Brain Behav Immun，2015，48:42-47.
[14] van Donkelaar EL，Vaessen KR，Pawluski JL，et al. Long-term corticosterone exposure decreases insulin sensitivity and induces depressive-like behaviour in the C57BL/6NCrl mouse. PLoS One，2014，9（10）:e106960.
[15] Lin EJ，Sun M，Choi EY，et al. Social overcrowding as a chronic stress model that increases adiposity in mice. Psychoneuroendocrinology，2015，51:318-330.
[16] Mazzone L，Postorino V，De Peppo L，et al. Paediatric non-alcoholic fatty liver disease:impact on patients and mothers' quality of life. Hepat Mon，2013，13（3）:e7871.
[17] Weinstein AA，Kallman Price J，Stepanova M，et al. Depression in patients with nonalcoholic fatty liver disease and chronic viral hepatitis B and C. Psychosomatics，2011，52（2）:127-132.
[18] Youssef NA，Abdelmalek MF，Binks M，et al. Associations of depression，anxiety and antidepressants with histological severity of nonalcoholic fatty liver disease. Liver Int，2013，33（7）:1062-1070.
[19] Lee K，Otgonsuren M，Younoszai Z，et al. Association of chronic liver disease with depression:a Population-based study. Psychosomatics，2013，54（1）:52-59.
[20] Scott KA，Melhorn SJ，Sakai RR. Effects of chronic social stress on obesity. Curr Obes Rep，2012，1（1）:16-25.
[21] Woods CP，Hazlehurst JM，Tomlinson JW. Glucocorticoids and non-alcoholic fatty liver disease. J Steroid Biochem Mol Biol，2015，154:94-103.
[22] 田颖新，王冰，邱红.糖皮质激素在非酒精性脂肪肝发展中的作用. 肝脏，2015，20（1）:79-81.
[23] Saltiel AR. Insulin resistance in the defense against obesity. Cell Metab，2012，15（6）:798-804.
[24] Wieck A，Grassi-Oliveira R，Hartmann do Prado C，et al. Neuroimmuno-endocrine interactions in post-traumatic stress disorder:focus on long-term implications of childhood maltreatment. Neuroimmunomodulation，2014，21（2-3）:145-151.
[25] Mathews EH，Liebenberg L. A practical quantification?of blood?glucose production due to high-level chronic stress. Stress Health，2012，28（4）:327-332.
[26] 张艳，武成，李慧吉，等. 心理防御机制对2型糖尿病患者血糖的影响.临床心身疾病杂志，2015，21，（2）:1-5.
[27] Nirupama R，Devaki M，Yajurvedi HN. Chronic stress and carbohydrate metabolism:persistent changes and slow return to normalcy in male albino rats. Stress，2012，15（3）: 262-271.
[28] Chuang JC， Cui H，Mason BL，et al. Chronic social defeat stress disrupts regulation of lipid synthesis. J Lipid Res，2010， 51（6）:1344-1353.
[29] Caslin HL，Franco RL，Crabb EB，et al. The effect of obesity on inflammatory cytokine and leptin production following acute mental stress. Psychophysiology，2015，doi:10.1111/psyp.12568. [Epub ahead of print]
[30] Nigam P，Bhatt SP，Misra A，et al. Non-alcoholic fatty liver disease is closely associated with sub-clinical inflammation:a case-control study on Asian Indians in North India. PLoS One，2013，8（1）:e49286.
[31] Passos E，Pereira CD，Goncalves IO，et al. Role of physical exercise on hepatic insulin，glucocorticoid and inflammatory signaling pathways in an animal model of non-alcoholic steatohepatitis. Life Sci，2015，123:51-60.
[32] Furtado M，Katzman MA. Examining the role of neuroinflammation in major depression. Psychiatry Res，2015，229（1-2）:27-36.
[33] Shelton RC，Miller AH. Inflammation in depression:is adiposity a cause Dialogues Clin Neurosci，2011，13（1）:41-53.
[34] Rossetti AC，Papp M，Gruca P，et al. Stress-induced anhedonia is associated with the activation of the inflammatory system in the rat brain:Restorative effect of pharmacological intervention. Pharmacol Res，2015，pii:S1043-6618（15）00262-5. doi:10.1016/j.phrs.2015.10.022. [Epub ahead of print]
[35] Hill MN，Hellemans KG，Verma P，et al. Neurobiology of chronic mild stress:Parallels to major depression. Neurosci Biobehav Rev，2012，36（9）:2085-2117.

Psychological stress in nonalcoholic fatty liver diseases

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Ren Yufei, Chen Xiaoqing, Kong Weizong, et al.. Effect of salvianolic acid B on autophagy in nonalcoholic fatty liver disease cell model in vitro [J]. Journal of Practical Hepatology, 2019, 22(6): 804-807.
[2]	Li Yingyi, Guo Cuifen, Zhang Ruinan, et al.. Correlation of polymorphism of ALDH2 rs671 to morbidity in individuals prone to nonalcoholic fatty liver disease [J]. Journal of Practical Hepatology, 2019, 22(6): 848-851.
[3]	Li Gaoming, Lyu Bihua. Effect of combination of entecavir and herbal medicine on negative emotion in patients with chronic hepatitis B and depression [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 498-501.
[4]	Zhang Lanhua, Shao Qin, Xia Zhenjuan. Changes of serum 25-(OH) D3 and IL-17 levels are associated with progress of nonalcoholic fatty liver disease in obese children [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 522-525.
[5]	Huo Huiqin, Gong Xiaohong, Li Zhenghong. Assessment of right atrial and ventricular functions in patients with nonalcoholic fatty liver disease-induced liver cirrhosis by real-time three-dimensional echocardiography and speckle tracking imaging [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 244-247.
[6]	Xie Xiao, Lu Lungen. Noninvasive diagnosis and assessment of patients with nonalcoholic steatohepatitis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 301-306.
[7]	Tian Yindi, Wang Yikai, Li Jing, et al.. Evaluation of reliability and validity of self-rating anxiety scale and self-rating depression scale in patients with liver cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 105-108.
[8]	Zhong Yan, Su Shuting, Mi Yuqiang.. Treatment of patients with nonalcoholic fatty liver disease [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 145-148.
[9]	Huang Jiaofeng, Lin Su, Wang Mingfang, et al.. Impact of entecavir therapy on hepatic steatosis in patients with chronic hepatitis B and nonalcoholic fatty liver disease [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 863-867.
[10]	Huang Faguang, Li Xiaocheng, Gong Jianping, et al.. Research on insulin resistance related protein molecules in human liver tissues by comprehensive gene expression profiling analysis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 872-876.
[11]	Pu Yonglan, Chen Yuanwen, Fan Jiangao.. Gluten intestinal disease and nonalcoholic fatty liver: One case report [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 981-982.
[12]	Yan Chenli, Wang Jingjing, Wang Jun.. Severity of coronary artery lesions and risk factors in patients with nonalcoholic fatty liver disease complicated by coronary heart disease [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 737-740.
[13]	Bing Hao, Li Yiling.. Correlation between non-alcoholic fatty liver disease and hepatocellular carcinoma:Fact or fiction [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 821-824.
[14]	Wang Xinwei, Lyu Ke, Sun Xiao, et al. Effect of selective β3-adrenergic receptor agonist on hepatic oxidative stress and liver fibrosis in rats with nonalcoholic fatty liver disease [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 384-387.
[15]	Li Caihong, Lian Lingling, Lu Derong. Preliminary trial of ezetimibe combined with atorvastatin in treatment of patient with nonalcoholic fatty liver disease complicated by coronary heart disease [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 405-408.